TAES for FPVCs: a Pragmatic, Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 4, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Premature Ventricular Complexes
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation (TAVNS)

Patients in TAVNS group will receive TAVNS and usual care. TAVNS will be performed on Erzhong and Xin (Auricular Acupuncture Point with vagus nerve distribution) for 6 weeks by using the Huato type SDZ-V stimulator; Usual Care: usual medicine treatment for PVCs.

DEVICE

Sham Transcutaneous Auricular Vagus Nerve Stimulation (Sham-TAVNS)

Patients in sham-TAVNS group will receive sham-TAVNS and usual care. Sham-TAVNS will be also performed on Erzhong and Xin (Auricular Acupuncture Point with vegas nerve stimulation) for 6 weeks by using a special Huato type SDZ-V stimulator. We cut the inner electric wire of the stimulator; therefore, there is no current output. Usual Care: usual medicine treatment for PVCs.

Trial Locations (1)

100053

RECRUITING

Guang'anmen Hospita, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
collaborator

China Association for Science and Technology

UNKNOWN

lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER